#	Pagina
attuale pagina	/open-h2020/projects/193647/index.html
-1	/open-fp7/projects/109557/index.html

Opendata, web and dolomites

FLDcure

A potent Micro-RNA therapeutic for nonalcoholic fatty liver disease (NAFLD)

Total Cost €

EC-Contrib. €

Partnership

Views

FLDcure project word cloud

Explore the words cloud of the FLDcure project. It provides you a very rough idea of what is the project "FLDcure" about.

cancer perportion company pathogenesis dramatically agent nonalcoholic pharmaceutical fld progress shown trials encourage mouse liver disease microrna benefits extend reduce cirrhosis clinical fatty treatment population license health model pursue prompt steatohepatitis therapeutic huge

Project "FLDcure" data sheet

The following table provides information about the project.

Coordinator	THE HEBREW UNIVERSITY OF JERUSALEM Organization address address: EDMOND J SAFRA CAMPUS GIVAT RAM city: JERUSALEM postcode: 91904 website: www.huji.ac.il contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Israel [IL]
Total cost	149˙800 €
EC max contribution	149˙800 € (100%)
Programme	1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
Code Call	ERC-2014-PoC
Funding Scheme	ERC-POC
Starting year	2015
Duration (year-month-day)	from 2015-01-01 to 2016-06-30

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	THE HEBREW UNIVERSITY OF JERUSALEM THE HEBREW UNIVERSITY OF JERUSALEM Organization address address: EDMOND J SAFRA CAMPUS GIVAT RAM city: JERUSALEM postcode: 91904 website: www.huji.ac.il contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	IL (JERUSALEM)	coordinator	149˙800.00

Map

Project objective

Fatty Liver disease (FLD) is a widespread disease which can often progress to Nonalcoholic steatohepatitis, cirrhosis and liver cancer. At present FLD disease affects a huge perportion of the population and prompt treatment will be of major health benefits to the general population. We have developed a specific therapeutic targeting a microRNA we and others have shown to be involved in the pathogenesis of FLD. This therapeutic agent can dramatically reduce FLD in a mouse model. We would like to extend the pre-clinical studies in order to encourage interest of a pharmaceutical company who will license the technology and pursue clinical trials.

Publications

List of publications.
year	authors and title	journal	last update
2016	Shani Shenhar-Tsarfaty Itzhak Shapira Sharon Toker Ori Rogowski Shlomo Berliner , Yaacov Ritovd and Hermona Soreqa1 Weakened Cholinergic Blockade of Inflammation Associates with DiabetesRelatedDepression published pages: , ISSN: 1076-1551, DOI: 10.2119/molmed	Molecular Medicine 2016 Apr 4;22	2019-07-22

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "FLDCURE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "FLDCURE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

CITISENSE (2019)

Evolving communication systems in response to altered sensory environments

GUTSY (2019)

The gut microbiota and its systemic effects on metabolism and atherosclerotic disease

CountIce (2020)

A portable instrument (PINE) for the autonomous detection of atmospheric ice nucleating particles aimed at the research, global monitoring and cloud seeding markets